Its talc-based powder, which has not been sold in the United States and Canada since 2020, has been the focus of dozens of lawsuits filed by women who later developed ovarian cancer. use Common talcum powder
Johnson & Johnson says they are confident in the product’s safety. But, in a statement on Friday, the company said it will stop selling the talc-based powder worldwide next year as part of a “global capital review”.
“We continuously evaluate and optimize our portfolio to best position the business for long-term growth,” the company said in a statement. “This transition will help us simplify our product offerings, deliver sustainable innovation and meet the needs of our customers, clients and evolving global trends.”
A handful of talcum powder companies put warning labels on their products, but Johnson and Johnson (JNJ) Argued that such a label is confusing because it stands with its product. Some scientific studies have shown that using talc in the genital area increases the risk of ovarian cancer in women, while others do not.
A lawsuit has been filed against the company alleging that asbestos in the company’s talcum powder causes cancer. A St. Louis jury awarded a $4.7 billion verdict against the company in 2018, alleging that the company was negligent and did not warn consumers of potential health risks from its baby powder.
“Our position on the safety of our cosmetic talc remains unchanged. We stand firmly behind decades of independent scientific analysis by medical experts around the world confirming that talc-based Johnson’s Baby Powder is safe, asbestos-free and non-carcinogenic,” it said in a statement on Friday.